Rowland & CO Investment Counsel Bio Rad Laboratories, Inc. Transaction History

Rowland & CO Investment Counsel

  • $472 Million
  • Q4 2024

A detailed history of Rowland & CO Investment Counsel transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 853 shares of BIO stock, worth $222,795. This represents 0.06% of its overall portfolio holdings.

Number of Shares
853
Previous 883 3.4%
Holding current value
$222,795
Previous $295,000 5.08%
% of portfolio
0.06%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025
SELL
$313.15 - $374.28 $9,394 - $11,228
-30 Reduced 3.4%
853 $280,000
Q3 2024

Oct 23, 2024
SELL
$263.97 - $344.64 $25,077 - $32,740
-95 Reduced 9.71%
883 $295,000
Q2 2024

Jul 29, 2024
SELL
$268.26 - $339.48 $20,119 - $25,461
-75 Reduced 7.12%
978 $267,000
Q1 2024

Apr 08, 2024
SELL
$304.11 - $351.99 $5,473 - $6,335
-18 Reduced 1.68%
1,053 $364,000
Q4 2023

Jan 03, 2024
SELL
$269.37 - $365.04 $5,387 - $7,300
-20 Reduced 1.83%
1,071 $345,000
Q3 2023

Oct 26, 2023
SELL
$350.25 - $422.63 $47,634 - $57,477
-136 Reduced 11.08%
1,091 $391,000
Q2 2023

Aug 04, 2023
SELL
$359.49 - $486.4 $84,480 - $114,304
-235 Reduced 16.07%
1,227 $465,000
Q1 2023

Apr 25, 2023
SELL
$418.69 - $503.0 $106,765 - $128,265
-255 Reduced 14.85%
1,462 $700,000
Q3 2022

Oct 06, 2022
BUY
$412.59 - $563.26 $26,818 - $36,611
65 Added 3.93%
1,717 $716,000
Q2 2022

Aug 15, 2022
BUY
$463.67 - $597.16 $34,775 - $44,787
75 Added 4.76%
1,652 $817,000
Q1 2022

Apr 26, 2022
BUY
$524.57 - $735.42 $125,896 - $176,500
240 Added 17.95%
1,577 $888,000
Q4 2021

Feb 14, 2022
BUY
$708.84 - $794.68 $477,758 - $535,614
674 Added 101.66%
1,337 $1.01 Million
Q3 2021

Nov 08, 2021
SELL
$657.71 - $825.77 $443,296 - $556,568
-674 Reduced 50.41%
663 $494,000
Q2 2021

Aug 09, 2021
BUY
$576.64 - $649.04 $66,313 - $74,639
115 Added 9.41%
1,337 $861,000
Q1 2021

May 11, 2021
BUY
$547.01 - $662.35 $160,273 - $194,068
293 Added 31.54%
1,222 $697,000
Q4 2020

Feb 11, 2021
BUY
$510.68 - $643.45 $474,421 - $597,765
929 New
929 $541,000
Q3 2020

Nov 12, 2020
SELL
$454.43 - $535.6 $301,287 - $355,102
-663 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$334.87 - $493.06 $222,018 - $326,898
663 New
663 $299,000

Others Institutions Holding BIO

# of Institutions
478
Shares Held
19.2M
Call Options Held
15.7K
Put Options Held
11.5K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.43B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Rowland & CO Investment Counsel Portfolio

Follow Rowland & CO Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email